Atlas Trials

Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

Clinical trial NCT01697020 · COMPLETED

Trial details

NCT number
NCT01697020
Sponsor
Nova Laboratories Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2012-09-01
Primary completion
2012-11-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.